Preoperative regional cerebral blood flow and postoperative clinical improvement in patients with Parkinson's disease undergoing subthalamic nucleus deep brain stimulation

Neurologia Medico-Chirurgica

Volumn 52, Issue 12, 2012, Pages 865-872

  Nagai, Toshiya ^a   Kajita, Yasukazu ^a   Maesawa, Satoshi ^b   Nakatsubo, Daisuke ^c   Yoshida, Kota ^d   Kato, Katsuhiko ^e   Wakabayashi, Toshihiko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sakura Hospital   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^d Higashikani Hospital   (Japan)

^e NAGOYA UNIVERSITY   (Japan)

Author keywords

Cerebral blood flow study; Deep brain stimulation; Parkinson's disease

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; ENTACAPONE; IOFETAMINE I 123; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; BRAIN BLOOD FLOW; BRAIN DEPTH STIMULATION; CEREBELLUM; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; FRONTAL LOBE; FUSIFORM GYRUS; GENERAL CONDITION IMPROVEMENT; HUMAN; INFERIOR PARIETAL GYRUS; MAJOR CLINICAL STUDY; MALE; MIDDLE FRONTAL GYRUS; MIDDLE OCCIPITAL GYRUS; MIDDLE TEMPORAL GYRUS; MOTOR PERFORMANCE; OCCIPITAL GYRUS; OUTCOME ASSESSMENT; PARIETAL GYRUS; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEREOTACTIC PROCEDURE; SUBTHALAMIC NUCLEUS; SUPERIOR FRONTAL GYRUS; SUPERIOR PARIETAL GYRUS; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; AUTORADIOGRAPHY; BRAIN; DEEP BRAIN STIMULATION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IOFETAMINE; JAPAN; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; POSTOPERATIVE COMPLICATIONS; RADIOPHARMACEUTICALS; REGIONAL BLOOD FLOW; SUBTHALAMIC NUCLEUS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84871699526     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.52.865     Document Type: Article

References (31)

1. Albin RL, Young AB, Penney JB: The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366-375, 1989
2. Alexander GE, Crutcher MD: Functional architecture of basal ganglia circuits neural substrates of parallel processing. Trends Neurosci 13: 266-271, 1990
3. Antonini A, Landi A, Benti R, Mariani C, De Notaris R, Marotta G, Pezzoli G, Gaini SM, Gerundini P: Functional neuroimaging (PET and SPECT) in the selection and assessment of patients with Parkinson's disease undergoing deep brain stimulation [review]. J Neurosurg Sci 47: 40-46, 2003
4. Antonini A, Moeller JR, Nakamura T, Spetsieris P, Dhawan V, Eidelberg D: The metabolic anatomy of tremor in Parkinson's disease. Neurology 51: 803-810, 1998
5. Ashburner J Friston KJ: Nonlinear spatial normalization using basis functions. Hum Brain Mapp 7: 165-189, 1997
6. Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, Horak FB, Okun MS, Foote KD, Krack P, Pahwa R, Henderson JM, Hariz MI, Bakay RA, Rezai A, Marks WJ Jr, Moro E, Vitek JL, Weaver FM, Gross RE, DeLong MR: Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 68: 165, 2010
7. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Boätzel K, Daniels C, Deutschländer A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J; German Parkinson Study Group, Neurostimulation Section: A randomized trial of deep-brain stimulation for Parkinson's disease. NEngl JMed 355: 896-908, 2006. Erratum in:NEngl J Med 355: 1289, 2006
8. Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ Jr, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ; CSP 468 Study Group: Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 362: 2077-2091, 2010
9. Friston KJ, Ashburner J, Frith CD, Poline J-B, Heather JD, Frackowiak RSJ: Spatial registration and normalization of images. Hum Brain Mapp 3: 165-189, 1955
10. Henriksen L, Boas J: Regional cerebral blood flow in hemiparkinsonian patients: emission computerized tomography of inhaled 133xenon before and after levodopa. Acta Neurol Scand 71: 257-266, 1985
11. Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M, Lehrke R, Koulousakis A, Herholz K, Sturm V, Heiss WD: Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDGPET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 24: 7-16, 2004
12. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A: The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 32: 181-185, 1992
13. Hornykiewcz O: Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 18: 925-964, 1966
14. Hsu JL, Jung TP, Hsu CY, Chen YK, Duann JR, Wang HC, Makeig S: Regional CBF changes in Parkinson's disease: a correlation with motor dysfunction. Eur J Nucl Med Mol Imaging 34: 1458-1466, 2007
15. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184, 1992
16. Iida H, Itoh H, Bloomfield PM, Munaka M, Higano S, Murakami M, Inugami A, Eberl S, Aizawa Y, Kanno: A method to quantitate cerebral blood flow using a rotating gamma camera and iodine-123 iodoamphetamine with one blood sampling. Eur J Nucl Med 21: 1072-1084, 1994
17. Iida H, Itoh H, Nakazawa M, Hatazawa J, Nishimura H, Onishi Y, Uemura K: Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med 35: 2019-2030, 1994
18. Kuhl DE, Metter EJ, Riege WH: Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method. Ann Neurol 15: 419-424, 1984
19. Laere KV, Santens P, Bosman T, Jacques De, Reuck JDE, Mortelmans L, Dierckx R: Statistical parametric mapping of 99mTc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonism feature: Correlation with clinical parameters. J Nucl Med 45: 933-942, 2004
20. Lancaster JL, Rainey LH, Summerlin JL, Freitas CS, Fox PT, Evans AF, Toga AW, Mazziotta JC: Automated labeling of the human brain: A preliminary report on development and evaluation of a Forward transform method. Hum Brain Mapp 5: 238-242, 1997
21. Lancaster JL, Woldoff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, Kochunov PV, Nickerson D, Mikiten SA, Fox PT: Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10: 120-131, 2000
22. Minoshima S, Berger KL, Lcc KS, Mintun MA: An automated method for rotational correction and centering of three-dimensional functional brain images. J Nucl Med 33: 1579-1585, 1992
23. Minoshima S, Koeppe RA, Frey KA, Kuhl DE: Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med 35: 1528-1537, 1994
24. Mito Y, Yoshida K, Yabe I, Makino K, Tashiro K, Kikuchi S, Sasaki H: Brain SPECT analysis by 3DSSP and phenotype of Parkinson's disease. J Neurol Sci 241: 67-72, 2006
25. Mizumura S, Kumita S, Cho K, Ishihara M, Nakajo H, Kumazaki T: Development of quantitative analysis method for stereotactic brain image; assessment of reduced accumulation in extent and severity using anatomical segmentation. Ann Nucl Med 17: 289-295, 2003
26. Okun MS, Foote KD: Parkinson's disease DBS: what, when, who and why? The time has come to tailor DBS targets. Expert Rev Neurother 10: 1847-1857, 2010
27. Parent B, Awan N, Berman SB, Suski V, Moore R, Crammond D, Kondziolka D: The relevance of age and disease duration for intervention with subthalamic nucleus deep brain stimulation surgery in Parkinson disease. J Neurosurg 114: 931-937, 2011
28. Shimizu S, Hanyu H, Kanetaka H, Iwamoto T, Koizumi K, Abe K: Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT. Dement Geriatr Cogn Disord 20: 25-30, 2005
29. Talairach J, Tournoux P: Co-planar Stereotactic Atlas of Human Brain. New York, Thieme Medical Publishers, 1988
30. Wächter T, Mf{hook}ánguez-Castellanos A, Valldeoriola F, Herzog J, Stoevelaar H: A tool to improve pre-selection for deep brain stimulation in patients with Parkinson's disease. J Neurol 258: 641-646, 2010
31. Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein J, Stoner G, Heemskerk J, Huang GD; CSP 468 Study Group: Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301: 63-73, 2009